Patent applications published 12 January 2011
Selected patent applications from the weekly European Patents Bulletin
- Methods for treating a condition characterised by dysfunction in protein homeostasis
The Scripps Research Institute 2271213*
- Pharmaceutical solutions and method for solubilising therapeutic agents
Particle Sciences 2271214*
- Use and compsn for treating dementia
Chase Pharmaceuticals 2271218*
- Nerve repair with a hydrogel and optional adhesive
University of Florida Research Foundation 2271312*
- Novel solid forms of bendamustine hydrochloride
Cephalon 2271315*
- Fenofibrate dosage forms
Elan Pharma International; Fournier Laboratories Ireland 2271316*
- Method for manufacturing acid pellets
Boehringer Ingelheim International 2271317*
- Pharmaceutical depot comprising N-(5-T-(cyclopropylamino)-arbonyl]-2-methylphenyl]-3-fluoro-4-(pyridin-2-ylmethoxy)-benzamide
AstraZeneca 2271318*
- Formulation with a reduced hygroscopicity
Bayer Technology Services 2271319*
- Raloxifene pharmaceutical formulations
Dr Reddy’s Laboratories Ltd; Dr Reddy’s Laboratories Inc 2271320*
- Pharmaceutical compsn 271
AstraZeneca 2271321*
- Encapsulation of biologically active agents
Glaxo Group 2271322*
- Encapsulation of biologically active agents
Glaxo Group 2271323*
- Encapsulation of biologically active agents
Glaxo Group 2271324*
- Methods and use of inducing apoptosis in cancer cells
Cytotech Labs 2271325*
- Modulation of fibroblast activity
The University of Leicester 2271326*
- Pharmaceutical compsn comprising rimeporide for treating diseases associated with insulin resistance and beta-cell dysfunction
Merck Patent 2271327*
- Antiseptic compsns for the treatment of infections
Alsa Pharmaceuticals 2271328*
- Methods, compsns and kits for treating pain and pruritis
President and Fellows of Harvard College; The General Hospital Corp 2271329*
- Extended release hydrocodone acetaminophen and related methods and uses thereof
Abbott Laboratories 2271330*
- Compsns and devices for antisepsis and anticoagulation
Gottardi, Waldemar 2271331*
- Use of compounds in the treatment of Tau-induced cytotoxicities
Bioalvo-Seriços, Investigaçao E Desenvolvimento Em Biotecnologia 2271332*
- Induction of proliferation, effector molecule expression, and cytolytic capacity of HIV-specific CD8+ T cells
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 2271333*
- Methods of treating fibrotic disorders
Paloma Pharmaceuticals 2271334*
- Improved statin production
DSM IP Assets 2271335*
- Process for extracting coumarins
Darome 2271336*
- Beta-turn peptidomimetic cyclic compounds for treating dry eye
Mimetogen Pharmaceuticals 2271337*
- Methods for treating neurological disorders with imidazolium and imidazolinium compounds
Agency for Science, Technology & Research, Singapore 2271338*
- ONO1910.NA enhances chemotherapeutic agent activity in drug-resistant tumours
The Johns Hopkins University 2271339*
- Pharmaceutical preparation comprising stephaglabrin sulphate for treating demyelinating diseases of the nervous system and for promoting restoration of the myelin sheath of nerve fibres
Zakrytoe Aktsionernoe Obschestvo “Biogen Technologies” 2271340*
- Specific inhibitors for vascular endothelial growth factor receptors
Nova Southeastern University 2271341*
- Salts of 2-substituted quinolines
Institut De Recherche Pour Le Developpement 2271343*
- Methods of treating disease-induced ataxia and non-ataxic imbalance
University of South Florida 2271344*
- HCV NS3 protease inhibitors
Merck Sharp & Dohme 2271345*
- Monocyclic CGRP receptor antagonists
Merck Sharp & Dohme 2271346*
- Administration of benzodiazepine compsns
Hale Biopharma Ventures 2271347*
- Oral and injectable formulations of tetracycline compounds
Paratek Pharmaceuticals 2271348*
- Compsns and methods for skin care
Antipodean Pharmaceuticals 2271349*
- Compsns and methods for immunotherapy
Cognate3 2271350*
- Compsns and methods for treating viral infections
Spring Bank 2271351*
- Compsns and methods for treatment of neoplastic disease
Innate Therapeutics 2271352*
- Vaccine
GlaxoSmithKline Biologicals 2271360*
- Method and vaccine for optimising the specific immune responses
Université de Lausanne 2271361*
- Novel antibodies against cancer target block tumour growth, angiogenesis and metastasis
The Regents of the University of California 2271362*
- Combinations and methods for subcutaneous administration of immune globulin and hyaluronidase
Baxter Healthcare SA; Baxter Healthcare Inc; Halozyme 2271363*
- Modular method to prepare tetrameric cytokines with improved pharmacokinetics by the dock-and-lock (DNL) technology
IBC Pharmaceuticals 2271364*
- Regulation of fatty acid transporters
The Ludwig Institute for Cancer Research 2271365*
- Antibodies to Clostridium difficile spores and uses thereof
3M Innovative Properties 2271366*
- Poly(beta malic acid) with pendant leu-leu-leu tripeptide for effective cytoplasmic drug delivery
Cedars-Sinai Medical Centre 2271368*
- Rasagilene mesylate particles and process for the preparation thereof
Actavis Group 2271612*
- Hydroxymethylcyclohexyl amines
Grünenthal 2271613*
- Method for the continuous synthesis of an N-acylated compound, and equipment for implementing said method
Societe D’Exploitation De Produits Pour Les Industries Chimiques Seppic 2271614*
- Novel process for preparation of iopromide
LG Life Sciences 2271615*
- Sulphoperoxycarboxylic acids, their preparation and methods of use as bleaching and antimicrobial agents
Ecolab 2271616*
- Substituted 4-hydroxy-N-(4-hydroxyphenyl) indoles as estrogenic agents
Glaxo Group 2271617*
- Pharmaceutical compounds
Astex Therapeutics 2271618*
- Compounds and compsns as modulators of GPR119 activity
IRM LLC 2271619*
- Compsns and methods for inhibition of hepatocyte growth factory receptor C-Met signalling
The United States of America, as represented by the Secretary, Department of Health and Human Services 2271620*
- Pyridyl derivatives as CFTR modulators
Vertex Pharmaceuticals 2271621*
- Heteroaryl derivatives as CFTR modulators
Vertex Pharmaceuticals 2271622*
- Perpropionic acid compsn that is stable in a basic medium
Arkema France 2271623*
- Iminopyridine derivatives and use thereof
Takeda Pharmaceutical Company 2271624*
- Tetrahydroisoquinolines, pharmaceutical compsns containing them, and their use in therapy
Abbott; Abbott Laboratories 2271625*
- Tetrahydrophenanthidinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerisation inhibitors
Janssen Pharmaceutica 2271626*
- Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
The General Hospital Corp 2271627*
- Benzimidazole derivatives as calcium channel blockers
Actelion Pharmaceuticals 2271628*
- Substituted pyrimidin-5-carboxamides 281
AstraZeneca 2271629*
- Compounds and compsns as protein kinase inhibitors
IRM LLC 2271630*
- Inhibitors of protein kinases
Portola Pharmaceuticals 2271631*
- 3-trifluoromethyl-pyrazine-2-carboxylic acid amide derivatives as HDL-cholesterol raising agents
F Hoffmann-La Roche 2271632*
- Method for producing chiral, epoxy ketones
Studiengesellschaft Kohle 2271633*
- Modulators of dopamine neurotransmission
NSAB 2271634*
- Modulators of dopamine neurotransmission
NSAB 2271635*
- Modulators of dopamine neurotransmission
NSAB 2271638*
- Piperidine derivatives as CGRP receptor antagonists
Bristol-Myers Squibb 2271640*
- Pyridinyl inhibitors of hedgehog signalling
Genentech; Curis 2271642*
- Compounds
Glaxo 2271643*
- Substituted piperidines as therapeutic compounds
Novartis 2271644*
- Compounds and compsns as kinase inhibitors
IRM LLC 2271645*
- Apoptosis signal-regulating kinase 1 inhibitors
Takeda Pharmaceutical 2271646*
- C2-fluoro substituted piperazine linked pyrrolo[2,1-C][1,4] benzodiazepine dimers and a process for the preparation thereof
Council of Scientific and Industrial Research, India 2271647*
- Isoxazoline linked pyrrolo [2,1-C][1,4]benzodiazepine hybrids as potential anticancer agents and the process for preparation thereof
Council for Scientific and Industrial Research, India 2271648*
- Bridged, bicyclic heterocyclic or spiro bicyclic heterocyclic derivatives of pyrazolo[1,5-A]pyrimidines, methods for preparation and uses thereof
Wyeth 2271649*
- Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands
Bristol-Myers Squibb 2271650*